Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Pfizer Inc,East 42nd street,New york, NY10017, USA
Femme et Homme Max 99 ans
Pfizer Inc,East 42nd street,New york, NY10017, USA
MAJ Il y a 4 ans
A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP MULTI-CENTER COMPARATIVE FLEXIBLE-DOSE STUDY OF PREGABALIN VERSUS LEVETIRACETAM AS ADJUNCTIVE THERAPY TO REDUCE SEIZURE FREQUENCY IN SUBJECTS WITH PARTIAL SEIZURES (A0081157)
To compare the efficacy of pregabalin and levetiracetam, at doses up to the maximal ones used in pivotal registration trials, as adjunctive therapy in subjects with refractory partial seizures, under ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Inc,East 42nd street,New york, NY10017, USA
MAJ Il y a 4 ans
A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, MULTI-CENTER, COMPARATIVE, FLEXIBLE DOSE TRIAL OF PREGABALIN VERSUS GABAPENTIN AS ADJUNCTIVE THERAPY IN SUBJECTS WITH PARTIAL SEIZURES
To compare the efficacy of pregabalin (300-600 mg/day flexible dose) and gabapentin (1200-1800 mg/day flexible dose), both administered three times daily (TID), as adjunctive therapy in subjects with ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations